Work

P-013 CERVINO: A Phase 3, Multicenter, Randomized, Open-Label Study of ABBV-383 Compared With Standard Available Therapies in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Year: 2024

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(24)01916-5

Authors: Luciano Costa, María-Victoria Mateos Manteca, Peter M. Voorhees, Shinsuke Iida, Craig Cole, Hang Quach, Rajvineeth Pothacamury, Orlando Bueno, Shane Lee, Tanya Rosenberg, Chetasi Talati, Shaji Kumar

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402735848

Cites:

Cited by:

Related to: 10